Universal Ibogaine Inc. reported earnings results for the second quarter and six months ended January 31, 2024. For the second quarter, the company reported sales was CAD 0.589468 million compared to CAD 0.041267 million a year ago. Net loss was CAD 0.222199 million compared to CAD 0.792858 million a year ago.
For the six months, sales was CAD 1.24 million compared to CAD 0.041267 million a year ago. Net loss was CAD 0.430048 million compared to CAD 1.63 million a year ago.